Aurinia Pharmaceuticals I...

AI Score

XX

Unlock

8.04
-0.15 (-1.83%)
At close: Apr 03, 2025, 3:59 PM
8.01
-0.44%
Pre-market: Apr 04, 2025, 04:31 AM EDT

Aurinia Pharmaceuticals Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021
License, Royalty and Collaboration Revenue Revenue 12.27M 2.16M 2.23M 42.31M 13.73M 394K 72K 28.33M 25.5M 28.15M 21.49M 23.38M 14.64M 6.59M 30K
License, Royalty and Collaboration Revenue Revenue Growth +466.91% -2.96% -94.73% +208.10% +3385.79% +447.22% -99.75% +11.07% -9.40% +30.97% -8.06% +59.69% +122.09% +21870.00% n/a
Product Revenue 55.5M 55.03M 48.07M n/a 40.78M 41.1M 34.34M n/a n/a n/a n/a n/a n/a n/a n/a
Product Revenue Growth +0.86% +14.47% n/a n/a -0.78% +19.70% n/a n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Japan Revenue 17.55M 31.48M n/a 50M 200K 345K 300K
Japan Revenue Growth -44.24% n/a -100.00% +24900.00% -42.03% +15.00% n/a
Other Country Revenue n/a 89K 117K n/a n/a n/a n/a
Other Country Revenue Growth -100.00% -23.93% n/a n/a n/a n/a n/a
United States Revenue 157.96M 102.46M 45.49M n/a n/a n/a n/a
United States Revenue Growth +54.17% +125.25% n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 39.64M 44.93M 47.7M 50.07M 47.76M 47.08M 50.12M 47.47M 52.17M 51.53M 45.2M 44.24M 44.13M 43.79M 39.28M 38.78M 31.07M 15.54M 11.06M 7.25M 6.06M 4.95M 3.9M 3.5M 2.92M 3.46M 3.79M 3.12M 2.65M 2.9M 3.43M 2.23M 1.72M 1.83M 1.19M 1.56M 1.38M 1.41M 1.91M
Selling, General, and Administrative Revenue Growth -11.78% -5.79% -4.75% +4.84% +1.44% -6.07% +5.58% -9.00% +1.24% +14.02% +2.16% +0.26% +0.78% +11.47% +1.30% +24.82% +99.91% +40.50% +52.65% +19.55% +22.54% +26.79% +11.52% +19.67% -15.57% -8.68% +21.58% +17.66% -8.65% -15.35% +53.88% +29.78% -6.49% +53.94% -23.79% +13.33% -2.40% -25.77% n/a
Research and Development Revenue 3.05M 4.08M 5.55M 10.23M 13.61M 12.65M 13.16M 9.87M 10.97M 11.53M 12.62M 11.15M 20.07M 10.09M 9.83M 13.17M 4.8M 11.08M 13.84M 13.29M 17.79M 11.15M 10.63M 10.84M 11.15M 10.5M 8.89M 8.69M 10.81M 7.11M 7.33M 5.46M 3.34M 2.41M 3.32M 3.65M 4.67M 4.33M 3.33M
Research and Development Revenue Growth -25.32% -26.50% -45.73% -24.82% +7.55% -3.86% +33.31% -10.05% -4.79% -8.68% +13.19% -44.44% +98.85% +2.62% -25.35% +174.44% -56.66% -19.94% +4.09% -25.29% +59.53% +4.90% -1.92% -2.81% +6.17% +18.20% +2.26% -19.58% +52.06% -2.98% +34.11% +63.44% +38.90% -27.62% -8.98% -21.80% +7.85% +30.03% n/a